<!--The Official Report of Parliamentary Debates (Hansard) of the Legislative Council and the House of Assembly of the Parliament of South Australia are covered by parliamentary privilege. Republication by others is not afforded the same protection and may result in exposure to legal liability if the material is defamatory. You may copy and make use of excerpts of proceedings where (1) you attribute the Parliament as the source, (2) you assume the risk of liability if the manner of your use is defamatory, (3) you do not use the material for the purpose of advertising, satire or ridicule, or to misrepresent members of Parliament, and (4) your use of the extracts is fair, accurate and not misleading. Copyright in the Official Report of Parliamentary Debates is held by the Attorney-General of South Australia.-->
<hansard id="" tocId="" xml:lang="EN-AU" schemaVersion="1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xml="http://www.w3.org/XML/1998/namespace" xmlns:xsi="http://www.w3.org/2007/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:noNamespaceSchemaLocation="hansard_1_0.xsd">
  <name>House of Assembly</name>
  <date date="2009-02-17" />
  <sessionName>Fifty-First Parliament, Third Session (51-3)</sessionName>
  <parliamentNum>51</parliamentNum>
  <sessionNum>3</sessionNum>
  <parliamentName>Parliament of South Australia</parliamentName>
  <house>House of Assembly</house>
  <venue></venue>
  <reviewStage>published</reviewStage>
  <startPage num="1463" />
  <endPage num="1553" />
  <dateModified time="2022-08-06T14:30:00+00:00" />
  <proceeding>
    <name>Ministerial Statement</name>
    <text id="2009021728a00a9da3ec4d9980000814">
      <heading>Ministerial Statement</heading>
    </text>
    <subject>
      <name>Mental Health Patients, Heatwave Deaths</name>
      <text id="2009021728a00a9da3ec4d9980000815">
        <heading>MENTAL HEALTH PATIENTS, HEATWAVE DEATHS</heading>
      </text>
      <talker role="member" id="1806" kind="speech">
        <name>The Hon. J.D. LOMAX-SMITH</name>
        <house>House of Assembly</house>
        <electorate id="">Adelaide</electorate>
        <portfolios>
          <portfolio id="">
            <name>Minister for Education</name>
          </portfolio>
          <portfolio id="">
            <name>Minister for Mental Health and Substance Abuse</name>
          </portfolio>
          <portfolio id="">
            <name>Minister for Tourism</name>
          </portfolio>
          <portfolio id="">
            <name>Minister for the City of Adelaide</name>
          </portfolio>
        </portfolios>
        <startTime time="2009-02-17T17:34:00" />
        <text id="2009021728a00a9da3ec4d9980000816">
          <timeStamp time="2009-02-17T17:34:00" />
          <by role="member" id="1806">The Hon. J.D. LOMAX-SMITH (Adelaide—Minister for Education, Minister for Mental Health and Substance Abuse, Minister for Tourism, Minister for the City of Adelaide) (17:34):</by> I seek leave to make a ministerial statement.</text>
        <text id="2009021728a00a9da3ec4d9980000817">Leave granted.</text>
      </talker>
      <talker role="member" id="1806" kind="speech" continued="true">
        <name>The Hon. J.D. LOMAX-SMITH</name>
        <house>House of Assembly</house>
        <text id="2009021728a00a9da3ec4d9980000818">
          <by role="member" id="1806">The Hon. J.D. LOMAX-SMITH:</by>  I was asked a question by the deputy leader this afternoon relating to some patients in the mental health system. I have been informed that three patients taking clozapine, but with other medical conditions, did unexpectedly die during the recent heatwave. This is, of course, a personal tragedy for the families involved, and I express my condolences to them.</text>
        <page num="1528" />
        <text id="2009021728a00a9da3ec4d9980000819">There is a possibility that the medication may have been linked to those deaths through the cardiovascular effects of clozapine. So, as is protocol, the Adverse Drug Reaction Advisory Committee was informed and there is follow-up of other patients who may have been treated with the same drug. This matter is still under investigation, and the matter is being looked at by that committee.</text>
      </talker>
    </subject>
  </proceeding>
</hansard>